Selenium Deficiency Fuels Liver Cancer by Creating Immunosuppressive Environment

This groundbreaking study reveals how selenium deficiency creates an environment that helps liver cancer thrive and evade immune detection. The research addresses a critical gap in understanding why certain immune cells become dysfunctional in hepatocellular carcinoma (HCC), the most common form of liver cancer.

Using advanced single-cell RNA sequencing in mouse models, researchers identified a distinct population of aged, immunosuppressive neutrophils in liver tumors. These cells were characterized by depletion of Selenoprotein P (Sepp1), a key protein that transports selenium throughout the body. The team discovered that tumors actively deplete Sepp1, which impairs selenium uptake through cellular transport mechanisms.

The selenium deficiency triggered a cascade of molecular changes. Without adequate selenium, cells accumulated S-adenosylmethionine and increased specific histone modifications, creating an epigenetic landscape that promoted neutrophil senescence. These aged neutrophils then suppressed the immune system's ability to fight cancer.

Remarkably, selenium supplementation reversed these harmful effects. It restored Sepp1 expression, reduced neutrophil aging, and reinvigorated anti-tumor immunity. Most importantly, selenium enhanced the effectiveness of checkpoint inhibitor immunotherapy, suggesting a potential combination treatment strategy.

These findings have significant implications for liver cancer treatment and prevention. They suggest that maintaining adequate selenium levels could help preserve immune function and potentially improve outcomes for patients receiving immunotherapy. The research also highlights the importance of nutritional status in cancer progression and treatment response.